A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Socazolimab or Placebo Combined with Carboplatin and Etoposide in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Signal Transduction and Targeted Therapy（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined